About Immuneering Corporation Class A Common Stock
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Market Cap
$0.06B
Employees
66
Listed Since
July 30, 2021
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.immuneering.comPhone
617-500-8080
Headquarters
245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142
CIK
0001790340